via MedicalXpress
Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that 2, which are already FDA-approved for other illnesses, seem promising.
The FDA approval for other uses would greatly reduce the time needed to gain FDA approval of use in COVID-19. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
The investigators tested the drugs in Vero cells, a cell line developed from kidney cells of the African Green Monkey, which are commonly used to grow viruses for vaccine production.
An anti-helminthic drug called niclosamide demonstrated “very potent” antiviral activity against SARS-CoV-2, according to coauthors Sangeun Jeon, Meehyun Ko, and their collaborators, of the Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea. “Not surprisingly, its broad-spectrum antiviral effect has been well documented in the literature, including antiviral properties against SARS- and MERS-CoV,” they write.
A downside of niclosamide is low absorption, which undercuts the drug’s power by reducing the dose that reaches the target tissue. However, “Further development or drug formulation could enable effective delivery of this drug to the target tissue,” according to the report.
Despite substantially lower antiviral potency, ciclesonide, an inhaled corticosteroid used to treat asthma and allergic rhinitis, also showed promise against SARS-CoV-2. Intriguingly, the investigators note that a study published earlier this year ( by Matsuyama et al.) a treatment report of 3 patients infected by SARS-CoV-2, demonstrated antiviral activity and revealed the drug’s molecular target to be a viral protein called Nsp15.
“With its proven anti-inflammatory activity, ciclesonide may represent as a potent drug which can manifest [the] dual roles [of antiviral and anti-inflammatory] for the control of SARS-CoV-2 infection,” the investigators conclude. The anti-inflammatory activity might play a critical role in dampening or preventing the cytokine storms, an immune inflammatory overreaction that can kill COVID-19 patients.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
SARS-CoV-2
- WHO picks JN.1 variant for next set of COVID vaccines
The World Health Organization has recommended updating COVID-19 vaccine formulations to reflect the dominant SARS-CoV-2 variant, JN.1. Read more here.
- Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in Shanghai
We report a retrospective, population-based cohort study performed in Shanghai, China, using electronic databases with information on SARS-CoV-2 infections and vaccination history. We compared ...
- Common antibiotic Neosporin may shield against viral respiratory infections
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Scientists discover higher levels of CO₂ increase survival of viruses in the air and transmission risk
A new study has revealed for the first time the vital role carbon dioxide (CO2) plays in determining the lifespan of airborne viruses—namely SARS-CoV-2, the virus that causes COVID-19. It clearly ...
- Covid-19 Found in People’s Blood Months After Infection
A quarter of people had Covid-19 viral proteins in their blood up to 14 months after infection. These proteins in the blood indicate that SARS-CoV-2 keeps living in tissue reservoirs. The study used a ...
Go deeper with Google Headlines on:
SARS-CoV-2
[google_news title=”” keyword=”SARS-CoV-2″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Covid-19
- Covid-19 Pandemic Led To Growing Acceptance Of Doctors Withholding Treatment
According to a new study there is a steadily growing acceptance of the view that it could be ethically acceptable for doctors to refuse care.
- WHO: Antibiotics Overused in COVID-19 Patients During Pandemic
The overuse of antibiotics could have exacerbated the spread of antimicrobial resistance, according to the World Health Organization.
Go deeper with Google Headlines on:
Covid-19
[google_news title=”” keyword=”Covid-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]